Retinal neurodegeneration: early pathology in diabetes
ABSTRACT Normal vision depends on the normal function of retinal neurons, so vision loss in diabetes must ultimately be explained in terms of altered neuronal function. However, to date relatively little attention has been paid to the impact of diabetes on the neural retina. Instead, the focus of mo...
Gespeichert in:
Veröffentlicht in: | Clinical & experimental ophthalmology 2000-02, Vol.28 (1), p.3-8 |
---|---|
Hauptverfasser: | , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 8 |
---|---|
container_issue | 1 |
container_start_page | 3 |
container_title | Clinical & experimental ophthalmology |
container_volume | 28 |
creator | Lieth, Erich Gardner, Thomas W Barber, Alistair J Antonetti, David A |
description | ABSTRACT
Normal vision depends on the normal function of retinal neurons, so vision loss in diabetes must ultimately be explained in terms of altered neuronal function. However, to date relatively little attention has been paid to the impact of diabetes on the neural retina. Instead, the focus of most research has been primarily on retinal vascular changes, with the assumption that they cause altered neuronal function and consequently vision loss. An increasing body of evidence suggests that alterations in neuronal function and viability may contribute to the pathogenic mechanisms of diabetic retinopathy beginning shortly after the onset of diabetes. This view arises from neurophysiological, psychometric, histopathological and biochemical observations in humans and experimental animals. The collective evidence from past and recent studies supports the hypothesis that neurodegeneration, together with functional changes in the vasculature, is an important component of diabetic retinopathy. The authors invite other investigators to include the neural retina as a component of their studies so that the pathogenesis of diabetic retinopathy can be understood more clearly. |
doi_str_mv | 10.1046/j.1442-9071.2000.00222.x |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_72603403</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>72603403</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4022-d1a3d366e382b478a6477a229a76e5e5116969ee2a1ba68c44e9bf7bb25f0c643</originalsourceid><addsrcrecordid>eNqNkF1PwjAUQBujEUT_gtmTb5v9WsuMLwYRJUSIYnxsuu0Oi2PDdkT27x2y4KtPvUnPuW0OQh7BAcFcXC8Dwjn1IyxJQDHGAcaU0mB7hLqHi-N2FhzzDjpzbtmAIWXiFHUIYTxknHSReIHKFDr3CtjYMoUFFGB1ZcrixgNt89pb6-qjzMtF7ZnCS42OoQJ3jk4ynTu4aM8eensYzgeP_mQ6ehrcTfyENz_yU6JZyoQA1qcxl30tuJSa0khLASGEhIhIRABUk1iLfsI5RHEm45iGGU4EZz10td-7tuXXBlylVsYlkOe6gHLjlKQCM45ZA_b3YGJL5yxkam3NSttaEax2zdRS7XKoXRq1a6Z-m6lto162b2ziFaR_YhupAW73wLfJof73YjUYTpuh0f29blwF24Ou7acSkslQvT-P1Px1PJ7x-5kasR-pkohs</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>72603403</pqid></control><display><type>article</type><title>Retinal neurodegeneration: early pathology in diabetes</title><source>MEDLINE</source><source>Wiley Online Library Journals Frontfile Complete</source><creator>Lieth, Erich ; Gardner, Thomas W ; Barber, Alistair J ; Antonetti, David A</creator><creatorcontrib>Lieth, Erich ; Gardner, Thomas W ; Barber, Alistair J ; Antonetti, David A ; Penn State Retina Research Group</creatorcontrib><description>ABSTRACT
Normal vision depends on the normal function of retinal neurons, so vision loss in diabetes must ultimately be explained in terms of altered neuronal function. However, to date relatively little attention has been paid to the impact of diabetes on the neural retina. Instead, the focus of most research has been primarily on retinal vascular changes, with the assumption that they cause altered neuronal function and consequently vision loss. An increasing body of evidence suggests that alterations in neuronal function and viability may contribute to the pathogenic mechanisms of diabetic retinopathy beginning shortly after the onset of diabetes. This view arises from neurophysiological, psychometric, histopathological and biochemical observations in humans and experimental animals. The collective evidence from past and recent studies supports the hypothesis that neurodegeneration, together with functional changes in the vasculature, is an important component of diabetic retinopathy. The authors invite other investigators to include the neural retina as a component of their studies so that the pathogenesis of diabetic retinopathy can be understood more clearly.</description><identifier>ISSN: 1442-6404</identifier><identifier>EISSN: 1442-9071</identifier><identifier>DOI: 10.1046/j.1442-9071.2000.00222.x</identifier><identifier>PMID: 11345341</identifier><language>eng</language><publisher>Melbourne, Australia: Blackwell Science Pty</publisher><subject>Apoptosis ; diabetic retinopathy ; Diabetic Retinopathy - diagnosis ; electroretinogram (ERG) ; Electroretinography ; glia ; Humans ; Neuroglia - pathology ; Retinal Degeneration - diagnosis ; retinal neurons</subject><ispartof>Clinical & experimental ophthalmology, 2000-02, Vol.28 (1), p.3-8</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4022-d1a3d366e382b478a6477a229a76e5e5116969ee2a1ba68c44e9bf7bb25f0c643</citedby><cites>FETCH-LOGICAL-c4022-d1a3d366e382b478a6477a229a76e5e5116969ee2a1ba68c44e9bf7bb25f0c643</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1046%2Fj.1442-9071.2000.00222.x$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1046%2Fj.1442-9071.2000.00222.x$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,776,780,1411,27901,27902,45550,45551</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/11345341$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Lieth, Erich</creatorcontrib><creatorcontrib>Gardner, Thomas W</creatorcontrib><creatorcontrib>Barber, Alistair J</creatorcontrib><creatorcontrib>Antonetti, David A</creatorcontrib><creatorcontrib>Penn State Retina Research Group</creatorcontrib><title>Retinal neurodegeneration: early pathology in diabetes</title><title>Clinical & experimental ophthalmology</title><addtitle>Clin Exp Ophthalmol</addtitle><description>ABSTRACT
Normal vision depends on the normal function of retinal neurons, so vision loss in diabetes must ultimately be explained in terms of altered neuronal function. However, to date relatively little attention has been paid to the impact of diabetes on the neural retina. Instead, the focus of most research has been primarily on retinal vascular changes, with the assumption that they cause altered neuronal function and consequently vision loss. An increasing body of evidence suggests that alterations in neuronal function and viability may contribute to the pathogenic mechanisms of diabetic retinopathy beginning shortly after the onset of diabetes. This view arises from neurophysiological, psychometric, histopathological and biochemical observations in humans and experimental animals. The collective evidence from past and recent studies supports the hypothesis that neurodegeneration, together with functional changes in the vasculature, is an important component of diabetic retinopathy. The authors invite other investigators to include the neural retina as a component of their studies so that the pathogenesis of diabetic retinopathy can be understood more clearly.</description><subject>Apoptosis</subject><subject>diabetic retinopathy</subject><subject>Diabetic Retinopathy - diagnosis</subject><subject>electroretinogram (ERG)</subject><subject>Electroretinography</subject><subject>glia</subject><subject>Humans</subject><subject>Neuroglia - pathology</subject><subject>Retinal Degeneration - diagnosis</subject><subject>retinal neurons</subject><issn>1442-6404</issn><issn>1442-9071</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2000</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqNkF1PwjAUQBujEUT_gtmTb5v9WsuMLwYRJUSIYnxsuu0Oi2PDdkT27x2y4KtPvUnPuW0OQh7BAcFcXC8Dwjn1IyxJQDHGAcaU0mB7hLqHi-N2FhzzDjpzbtmAIWXiFHUIYTxknHSReIHKFDr3CtjYMoUFFGB1ZcrixgNt89pb6-qjzMtF7ZnCS42OoQJ3jk4ynTu4aM8eensYzgeP_mQ6ehrcTfyENz_yU6JZyoQA1qcxl30tuJSa0khLASGEhIhIRABUk1iLfsI5RHEm45iGGU4EZz10td-7tuXXBlylVsYlkOe6gHLjlKQCM45ZA_b3YGJL5yxkam3NSttaEax2zdRS7XKoXRq1a6Z-m6lto162b2ziFaR_YhupAW73wLfJof73YjUYTpuh0f29blwF24Ou7acSkslQvT-P1Px1PJ7x-5kasR-pkohs</recordid><startdate>200002</startdate><enddate>200002</enddate><creator>Lieth, Erich</creator><creator>Gardner, Thomas W</creator><creator>Barber, Alistair J</creator><creator>Antonetti, David A</creator><general>Blackwell Science Pty</general><scope>BSCLL</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>200002</creationdate><title>Retinal neurodegeneration: early pathology in diabetes</title><author>Lieth, Erich ; Gardner, Thomas W ; Barber, Alistair J ; Antonetti, David A</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4022-d1a3d366e382b478a6477a229a76e5e5116969ee2a1ba68c44e9bf7bb25f0c643</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2000</creationdate><topic>Apoptosis</topic><topic>diabetic retinopathy</topic><topic>Diabetic Retinopathy - diagnosis</topic><topic>electroretinogram (ERG)</topic><topic>Electroretinography</topic><topic>glia</topic><topic>Humans</topic><topic>Neuroglia - pathology</topic><topic>Retinal Degeneration - diagnosis</topic><topic>retinal neurons</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Lieth, Erich</creatorcontrib><creatorcontrib>Gardner, Thomas W</creatorcontrib><creatorcontrib>Barber, Alistair J</creatorcontrib><creatorcontrib>Antonetti, David A</creatorcontrib><creatorcontrib>Penn State Retina Research Group</creatorcontrib><collection>Istex</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Clinical & experimental ophthalmology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Lieth, Erich</au><au>Gardner, Thomas W</au><au>Barber, Alistair J</au><au>Antonetti, David A</au><aucorp>Penn State Retina Research Group</aucorp><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Retinal neurodegeneration: early pathology in diabetes</atitle><jtitle>Clinical & experimental ophthalmology</jtitle><addtitle>Clin Exp Ophthalmol</addtitle><date>2000-02</date><risdate>2000</risdate><volume>28</volume><issue>1</issue><spage>3</spage><epage>8</epage><pages>3-8</pages><issn>1442-6404</issn><eissn>1442-9071</eissn><abstract>ABSTRACT
Normal vision depends on the normal function of retinal neurons, so vision loss in diabetes must ultimately be explained in terms of altered neuronal function. However, to date relatively little attention has been paid to the impact of diabetes on the neural retina. Instead, the focus of most research has been primarily on retinal vascular changes, with the assumption that they cause altered neuronal function and consequently vision loss. An increasing body of evidence suggests that alterations in neuronal function and viability may contribute to the pathogenic mechanisms of diabetic retinopathy beginning shortly after the onset of diabetes. This view arises from neurophysiological, psychometric, histopathological and biochemical observations in humans and experimental animals. The collective evidence from past and recent studies supports the hypothesis that neurodegeneration, together with functional changes in the vasculature, is an important component of diabetic retinopathy. The authors invite other investigators to include the neural retina as a component of their studies so that the pathogenesis of diabetic retinopathy can be understood more clearly.</abstract><cop>Melbourne, Australia</cop><pub>Blackwell Science Pty</pub><pmid>11345341</pmid><doi>10.1046/j.1442-9071.2000.00222.x</doi><tpages>6</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1442-6404 |
ispartof | Clinical & experimental ophthalmology, 2000-02, Vol.28 (1), p.3-8 |
issn | 1442-6404 1442-9071 |
language | eng |
recordid | cdi_proquest_miscellaneous_72603403 |
source | MEDLINE; Wiley Online Library Journals Frontfile Complete |
subjects | Apoptosis diabetic retinopathy Diabetic Retinopathy - diagnosis electroretinogram (ERG) Electroretinography glia Humans Neuroglia - pathology Retinal Degeneration - diagnosis retinal neurons |
title | Retinal neurodegeneration: early pathology in diabetes |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-29T01%3A11%3A52IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Retinal%20neurodegeneration:%20early%20pathology%20in%20diabetes&rft.jtitle=Clinical%20&%20experimental%20ophthalmology&rft.au=Lieth,%20Erich&rft.aucorp=Penn%20State%20Retina%20Research%20Group&rft.date=2000-02&rft.volume=28&rft.issue=1&rft.spage=3&rft.epage=8&rft.pages=3-8&rft.issn=1442-6404&rft.eissn=1442-9071&rft_id=info:doi/10.1046/j.1442-9071.2000.00222.x&rft_dat=%3Cproquest_cross%3E72603403%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=72603403&rft_id=info:pmid/11345341&rfr_iscdi=true |